MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Merck & Co. Company Profile (NYSE:MRK)

Consensus Ratings for Merck & Co. (NYSE:MRK) (?)
Ratings Breakdown: 12 Hold Rating(s), 5 Buy Rating(s)
Consensus Rating:Hold (Score: 2.29)
Consensus Price Target: €59.64 (6.73% upside)

Analysts' Ratings History for Merck & Co. (NYSE:MRK)
Show:
DateFirmActionRatingPrice TargetActions
6/14/2016Jefferies GroupLower Price TargetHold$54.00 -> $53.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/9/2016ArgusReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/8/2016Goldman SachsReiterated RatingNeutral$60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/19/2016JPMorgan Chase & Co.Reiterated RatingOverweightView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/12/2016Bank of AmericaReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/9/2016Credit SuisseBoost Price TargetNeutral$56.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2016Societe GeneraleInitiated CoverageBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/5/2016Leerink SwannReiterated RatingMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/23/2016Morgan StanleyReiterated RatingHold$57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/5/2016S&P Equity ResearchReiterated RatingHold$56.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/4/2016BMO Capital MarketsLower Price TargetOutperform$60.00 -> $58.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2016Cowen and CompanyReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/18/2015Atlantic SecuritiesInitiated CoverageNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/1/2015BarclaysUpgradeEqual Weight -> Overweight$64.00 -> $66.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2015Berenberg BankInitiated CoverageHold$61.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/21/2015Sanford C. BernsteinLower Price Target$69.00 -> $64.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/6/2015Deutsche BankReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/10/2015Piper JaffrayReiterated RatingHold$62.00 -> $60.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/2/2014GuggenheimInitiated CoverageNeutral$65.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/28/2014Main First Bank AGUpgradeUnderperform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/7/2014Citigroup Inc.Boost Price TargetNeutral$44.00 -> $57.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/26/2014 forward)
Earnings History for Merck & Co. (NYSE:MRK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
7/29/2016        
5/5/2016Q116$0.85$0.89$9.45 billion$9.30 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2016Q415$0.91$0.93$10.32 billion$10.22 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2015Q315$0.91$0.96$10.11 billion$10.10 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/28/2015Q215$0.80$0.86$9.81 billion$9.80 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/28/2015Q115$0.75$0.85$9.04 billion$9.40 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/4/2015Q414$0.86$0.87$10.61 billion$10.48 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/27/2014Q314$0.88$0.90$10.66 billion$10.56 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2014Q214$0.80$0.85$10.60 billion$10.93 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2014Q114$0.79$0.88$10.44 billion$10.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/5/2014Q413$0.88$0.88$11.39 billion$11.30 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2013Q313$0.88$0.92$11.19 billion$11.03 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.82$0.84$11.22 billion$11.01 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/1/2013Q1 2013$0.79$0.85$11.09 million$10.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/1/2013Q4 2012$0.81$0.83$11.46 billion$11.70 billionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/26/2012Q312$0.92$0.95$11.60 billion$11.50 billionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/27/2012$1.02$1.05ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/27/2012$0.98$0.99ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/2/2012$0.95$0.97ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/28/2011$0.91$0.94ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/29/2011$0.94$0.95ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
4/29/2011$0.84$0.92ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/3/2011$0.83$0.88ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for Merck & Co. (NYSE:MRK)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.82$0.87$0.84
Q2 20161$0.88$0.88$0.88
Q3 20161$0.97$0.97$0.97
Q4 20162$0.96$1.02$0.99
(Data provided by Zacks Investment Research)
Current Dividend Information for Merck & Co. (NYSE:MRK)
Annual Dividend:$1.84
Dividend Yield:3.29%
Payout Ratio:49.46%
Dividend Growth:2.30% (3 Year Average)

Dividend History for Merck & Co. (NYSE:MRK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable DateShare
5/24/2016quarterly€0.463.25%6/13/20166/15/20167/8/2016Tweet This Announcement  Share This Announcement on StockTwits
2/23/2016quarterly€0.463.64%3/11/20163/15/20164/7/2016Tweet This Announcement  Share This Announcement on StockTwits
11/24/2015quarterly€0.463.43%12/11/201512/15/20151/8/2016Tweet This Announcement  Share This Announcement on StockTwits
7/22/2015quarterly€0.453.1%9/11/20159/15/201510/7/2015Tweet This Announcement  Share This Announcement on StockTwits
5/26/2015quarterly€0.453.03%6/11/20156/15/20157/8/2015Tweet This Announcement  Share This Announcement on StockTwits
2/24/2015quarterly€0.453.05%3/12/20153/16/20154/8/2015Tweet This Announcement  Share This Announcement on StockTwits
11/25/2014quarterly€0.453.01%12/11/201412/15/20141/8/2015Tweet This Announcement  Share This Announcement on StockTwits
7/23/2014quarterly€0.443.02%9/11/20149/15/201410/7/2014Tweet This Announcement  Share This Announcement on StockTwits
5/27/2014quarterly€0.443.12%6/12/20146/16/20147/8/2014Tweet This Announcement  Share This Announcement on StockTwits
2/25/2014quarterly€0.443.13%3/13/20143/17/20144/7/2014Tweet This Announcement  Share This Announcement on StockTwits
11/26/2013quarterly€0.443.53%12/12/201312/16/20131/8/2014Tweet This Announcement  Share This Announcement on StockTwits
7/24/2013quarterly€0.433.57%9/12/20139/16/201310/7/2013Tweet This Announcement  Share This Announcement on StockTwits
5/28/2013quarterly€0.433.67%6/13/20136/17/20137/8/2013Tweet This Announcement  Share This Announcement on StockTwits
2/26/2013quarterly€0.434%3/13/20133/15/20134/5/2013Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2013 forward)
Insider Trading History for Merck & Co. (NYSE:MRK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/20/2016Clark GolestaniEVPSell39,877€54.79€2,184,860.83View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/14/2016Kenneth C FrazierCEOSell131,040€56.11€7,352,654.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/4/2015Wendell P. WeeksDirectorSell5,000€55.53€277,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Adele D. AmbroseinsiderSell37,313€55.08€2,055,200.04View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/29/2015Kenneth C. FrazierCEOSell18,666€54.69€1,020,843.54View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/28/2015Peter C. WendellDirectorSell5,000€54.85€274,250.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/11/2015Adam H SchechterEVPSell10,634€60.44€642,718.96View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/8/2015Julie L GerberdingEVPSell38,368€60.99€2,340,064.32View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/4/2015Bruce N KuhlikInsiderSell56,064€60.20€3,375,052.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Bruce N KuhlikInsiderSell156,902€59.82€9,385,877.64View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/29/2015Michael J HolstonEVPSell95,624€59.84€5,722,140.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/18/2015Kenneth C FrazierCEOSell5,164€58.67€302,971.88View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2015Willie A DeeseInsiderSell135,864€58.56€7,956,195.84View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/9/2015Peter C WendellDirectorSell5,000€58.76€293,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/15/2015Adam H SchechterEVPSell74,200€62.48€4,636,016.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
1/9/2015Kenneth C FrazierCEOSell8,840€62.47€552,234.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/10/2014Kenneth C FrazierCEOSell9,846€60.00€590,760.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
12/8/2014Bruce N KuhlikInsiderSell50,000€62.00€3,100,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/26/2014Rochelle B LazarusDirectorSell10,000€59.63€596,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/24/2014Wendell P WeeksDirectorSell5,000€59.13€295,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/10/2014Kenneth C FrazierCEOSell10,000€57.98€579,800.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
10/10/2014Kenneth C FrazierCEOSell9,895€59.73€591,028.35View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/10/2014Kenneth C FrazierCEOSell9,814€60.48€593,550.72View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/25/2014Adam H SchechterEVPSell22,000€59.70€1,313,400.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/11/2014Kenneth C FrazierCEOSell10,058€57.00€573,306.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/4/2014Adele D AmbroseInsiderSell28,669€56.64€1,623,812.16View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/10/2014Kenneth C FrazierCEOSell9,987€58.03€579,545.61View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
7/7/2014Weir Mirian M GraddickInsiderSell180,047€59.16€10,651,580.52View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/27/2014Willie A DeeseInsiderSell72,290€58.26€4,211,615.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
6/10/2014Kenneth C FrazierCEOSell9,985€58.06€579,729.10View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/14/2014Adam SchechterEVPSell10,527€55.91€588,564.57View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/10/2014Kenneth FrazierCEOSell10,047€57.24€575,090.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
4/4/2014Bruce KuhlikInsiderSell145,225€56.43€8,195,046.75View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/14/2014Clark GolestaniEVPSell5,990€55.47€332,265.30View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/13/2014Bridgette HellerVPSell43,870€55.04€2,414,604.80View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Adam SchechterEVPSell18,000€55.61€1,000,980.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014John CananInsiderSell10,000€55.70€557,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/11/2014Kenneth FrazierCEOSell41,520€54.52€2,263,670.40View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Peter WendellDirectorSell5,000€54.44€272,200.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
2/10/2014Willie DeeseInsiderSell50,000€54.68€2,734,000.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/7/2013Willie DeeseInsiderSell50,638€48.55€2,458,474.90View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/15/2013Adele D AmbroseInsiderSell34,208€46.66€1,596,145.28View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
5/13/2013Bridgette P HellerVPSell5,404€46.15€249,394.60View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/9/2012Willie A DeeseInsiderSell62,324€44.26€2,758,460.24View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for Merck & Co. (NYSE:MRK)
DateHeadline
06/26/16 04:32 PMHC Stocks Newsbeat: Galena Biopharma Inc (NASDAQ:GALE), Merck & Co., Inc. (NYSE:MRK) - share market updates (press release)
06/25/16 04:52 PMMerck & Company Inc. (new) (MRK) Closes 3.12% Down on the Day for June 24
06/25/16 09:01 AMStock in Action: Merck & Co. Inc. (NYSE:MRK) - News Oracle
06/25/16 09:01 AMMerck & Company Inc. (new) (MRK) Closes 3.12% Down on the Day for June 24 - Equities.com
06/24/16 05:11 PMMerck & Co. Inc.: Merck to Hold Second-Quarter 2016 Sales and Earnings Conference Call on July 29
06/24/16 07:52 AMMerck : to Hold Second-Quarter 2016 Sales and Earnings Conference Call on July 29
06/24/16 07:52 AMMerck & Company Inc. (new) (MRK) Closes 1.12% Up on the Day for June 23
06/24/16 07:20 AMMerck to Hold Second-Quarter 2016 Sales and Earnings Conference Call on July 29 - [at noodls] - KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its second-quarter 2016 sales and earnings conference call with institutional investors ...
06/23/16 05:43 PMMerck & Company, Inc. (NYSE:MRK) Earnings Glance and Target Price Review - Engelwood Daily
06/23/16 05:43 PMStock under Analysts' radar: Merck & Co. Inc. (NYSE:MRK) - News Oracle
06/23/16 05:43 PMMerck & Company Inc. (new) (MRK) Closes 1.12% Up on the Day for June 23 - Equities.com
06/23/16 05:43 PMIs it Finally Safe to Buy Merck & Co Inc (NYSE:MRK)? - Street Report
06/22/16 05:09 PMEli Lilly and Co (NYSE:LLY) & Merck & Co., Inc. (NYSE:MRK) Healthcare Movers to Watch - Wall Street 24
06/22/16 05:09 PMMerck & Company Inc. (new) (MRK) Closes 0.2% Up on the Day for June 21 - Equities.com
06/22/16 05:09 PMAnalyst Review: Merck & Co. Inc. (NYSE:MRK) - News Oracle
06/22/16 05:09 PMCan Merck & Co., Inc. (NYSE:MRK)'s Gardasil Trigger More HPV Vaccine Coverage? - Market Exclusive
06/22/16 09:58 AMMerck (ETR:MRK) stock price target raised to EUR92 as recorded today by Morgan Stanley
06/22/16 09:58 AMThe Top Four Diabetes Best Sellers and One Oral Insulin Pill That May Threaten Them All
06/22/16 09:58 AMMerck & Company Inc. (new) (MRK) Closes 0.2% Up on the Day for June 21
06/21/16 09:43 AMMerck & Company Inc. (new) (MRK) Closes 0.45% Up on the Day for June 20
06/20/16 05:09 PMNokia Corp (ADR) (NYSE:NOK) & Merck & Co., Inc. (NYSE:MRK) Trader's Watch List - Wall Street 24
06/20/16 05:09 PMMerck & Company Inc. (new) (MRK) Closes 0.45% Up on the Day for June 20 - Equities.com
06/20/16 05:09 PMLast Analysts Rating Review: Merck & Company, Inc. (NYSE:MRK) , DENTSPLY International Inc. (NASDAQ:XRAY) - Street Updates
06/20/16 11:49 AMResults of Phase 2 Study of Merck’s Investigational Beta-Lactamase Inhibitor Relebactam in Combination with Imipenem/Cilastatin Presented at ASM Microbe - [at noodls] - KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that a Phase 2 study of relebactam, the company's investigational beta-lactamase ...
06/20/16 11:32 AM12:32 pm Merck announces that a Phase 2 study of relebactam in combination with imipenem/cilastatin, in patients with complicated UTIs, met its primary endpoint at ASM Microbe 2016 -
06/20/16 04:46 AMBNP PARIBAS reported on (ETR:MRK) Merck, raising its target price to EUR108 today
06/20/16 03:46 AMCalls For Actions Grow Louder -
06/19/16 04:43 PMBaader Wertpapierhandelsbank announced (ETR:MRK) Merck, stepping up its price target to EUR97 today
06/19/16 06:23 AM3 Top Big Pharma Stocks to Buy Now -
06/18/16 10:00 AMMeet the Marijuana Industry Money-Man, Rob Hunt of Tuatara Capital -
06/17/16 05:04 PMMerck & Company Inc. (new) (MRK) Closes 2.51% Up on the Day for June 16
06/17/16 05:04 PMMerck & Co., Inc. Wins This Round of the Immunotherapy Lung-Cancer Battle
06/17/16 08:01 AMMerck & Company Inc. (new) (MRK) Closes 2.51% Up on the Day for June 16 - Equities.com
06/17/16 08:01 AMBuzz Stocks: Rite Aid Corporation, Merck & Co., Inc., and Nu Skin Enterprises, Inc. - Schaeffers Research (blog)
06/17/16 08:01 AMMerck & Company Inc. (new) (MRK) Pops 2.51% for June 16 - Equities.com
06/17/16 08:01 AMStocks in Analyst's Eyes: Merck & Co. Inc. (NYSE:MRK), Verizon Communications Inc. (NYSE:VZ) - Beacon Chronicle
06/16/16 05:23 PMStocks shrugged off mixed economic data to end a five-day slide Thursday with these three looking especially stout
06/16/16 05:23 PMMerck & Co. Inc. Shares Jump On Positive Lung Cancer Treatment Trial Results
06/16/16 04:12 PMThis Key Merck Cancer Drug Just Got a Huge Boost -
06/16/16 09:33 AMMerck's stock surges on positive results from cancer-treatment study
06/16/16 09:33 AMMerck's KEYTRUDA Trial Meets Primary Endpoint In Advanced NSCLC Patients
06/16/16 09:33 AMMerck & Company Inc. (new) (MRK) Closes 0.28% Down on the Day for June 15
06/16/16 09:33 AMBuzz Stocks: Rite Aid Corporation, Merck & Co., Inc., and Nu Skin Enterprises, Inc.
06/16/16 09:04 AMNasdaq Undercuts 200-Day; Kroger, Merck Stocks Climb -
06/16/16 08:54 AMCramer's Stop Trading: 'Breakthrough' for Merck -
06/15/16 05:15 PMEye Catching Stock: Merck & Co. Inc. (NYSE:MRK) - News Oracle
06/15/16 03:46 PMRelypsa Sales Numbers Surprise to the Upside -
06/15/16 09:53 AMEarnings Estimates to see: Merck & Co. Inc. (NYSE:MRK) - News Oracle
06/15/16 09:53 AMStock Update: Merck & Co Inc (NYSE:MRK) – Merck Highlights Ongoing Commitment to Fighting Infectious Diseases ... - Jutia Group (press release) (blog)
06/15/16 09:53 AMTake a look at Analyst Tips: Merck & Company, Inc. (NYSE:MRK) , Sophiris Bio, Inc. (NASDAQ:SPHS) - Street Updates
About Merck & Co.

Merck & Co. logoMerck & Co., Inc. is a global healthcare company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products, which it markets directly and through its joint ventures. It operates through one segment, Pharmaceutical. The Company's Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. The Company sells these human health pharmaceutical products primarily to drug wholesalers and retailers, hospitals, government agencies and managed healthcare providers. The Animal Health segment discovers, develops, manufactures and markets animal health products, including vaccines. The Company's animal health products are sold to veterinarians, distributors and animal producers.

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: MRK
  • CUSIP: 58933Y10
Key Metrics:
  • Previous Close: $55.88
  • 50 Day Moving Average: $55.85
  • 200 Day Moving Average: $53.42
  • P/E Ratio: 34.26
  • P/E Growth: 4.48
  • Market Cap: $154.68B
  • Current Quarter EPS Consensus Estimate: $3.72 EPS
Additional Links:
Merck & Co. (NYSE:MRK) Chart for Sunday, June, 26, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha